Abstract
ABSTRACT The interrelationships in the regulation of thyroid-stimulating hormone (TSH) and prolactin (PRL) secretion in man were studied by following their response to drugs and hormones known to affect the serum concentration of either TSH or PRL. Administration of a single 0.5 oral dose of l-dopa to 12 patients with primary hypothyroidism produced a consistent suppression of the elevated TSH level in all patients. In contrast, l-dopa given to patient with known primary hypothyroidism, in whom thyroid hormone replacement therapy was discontinued for 3–4 weeks, produced suppression of TSH in only 2 out of patients, and there was no correlation between the basal TSH level and the responsiveness to l-dopa. The TSH response to l-dopa in a group of 13 euthyroid patients could not be interpreted due changes in TSH within the limits of the assay sensitivity. The TSH but not the PRL response to synthetic thyrotropin releasing hormone (TRH) was blunted early in the course of thyroid hormone replacement. After 2½ ...
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: The Journal of clinical endocrinology and metabolism
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
